Malassezia Sympodialis (Mala s 11) IgE Test · Blood

If you have eczema that keeps flaring on your face, scalp, or neck, the cause may not be in your laundry detergent or food. It may be a yeast that lives on almost everyone's skin called Malassezia sympodialis, and an allergic reaction your immune system has built against one of its proteins.

This test looks for an antibody (called IgE) against a specific Malassezia protein known as Mala s 11. When this antibody shows up at high levels, it usually points to a more severe, microbe-driven form of atopic dermatitis, the type that often resists standard creams and tends to cluster on the head and neck.

What This Test Actually Measures

Mala s 11 (manganese superoxide dismutase) is one specific protein made by the skin yeast Malassezia sympodialis. Your immune system can make an allergy antibody (IgE, short for immunoglobulin E) against this protein, and that antibody circulates in your blood. This test counts how much of that specific antibody you have.

What makes Mala s 11 unusual is how closely it resembles a protein your own body makes (also called manganese superoxide dismutase). Researchers describe this as a kind of mistaken-identity allergy, where the immune response to the yeast can also start reacting to your own tissue, helping fuel ongoing skin inflammation.

This is a research-grade component test, meaning it is one piece of a more detailed allergy workup rather than a standalone diagnostic. There are no universally agreed-upon cutoffs for what counts as high. Its value lies in giving you a more precise picture of what is driving your eczema, especially when broader allergy tests come back unclear.

Atopic Dermatitis and Disease Severity

The strongest signal in the research is the link to atopic dermatitis severity. Sensitization to Mala s 11 is uncommon in healthy people and in non-eczema skin conditions, but rises sharply in adults with significant eczema.

Source: Čelakovská et al., ALEX 2 study (2021); Mittermann et al. (2016); Brodská et al. (2014).

What this means for you: if your eczema is moderate or severe, a high Mala s 11 antibody result is consistent with a yeast-sensitized phenotype, which can change how aggressively a dermatologist thinks about microbial triggers in your skin care plan.

Head and Neck Eczema

Eczema that lives mostly above the collarbone has a specific name in research circles: head and neck atopic dermatitis. This pattern is closely tied to Malassezia, because the yeast thrives in oily skin areas like the scalp, forehead, sides of the nose, and upper chest.

A 2024 meta-analysis pooling multiple studies found Malassezia-specific antibodies present in roughly 79% of patients with head and neck eczema. A separate clinical study reported that hypersensitivity to Malassezia was found in about 80% of patients with the head and neck pattern, and the disease responded well to antifungal treatment.

What this means for you: if your eczema clusters on your face, scalp, or neck and is not responding well to standard topical steroids, a positive Mala s 11 or broader Malassezia antibody result is one of the clearest reasons to talk to a dermatologist about adding antifungal therapy.

Severe Eczema and Dupilumab-Related Skin Reactions

Dupilumab is a biologic medication used for severe eczema. Some patients on dupilumab develop a new or worsened head-and-neck dermatitis. In one published cohort, baseline Malassezia-specific antibody testing predicted this complication with high sensitivity and specificity, meaning it correctly flagged most people who later developed the reaction and correctly cleared most who did not.

What this means for you: if you are starting or already taking dupilumab, knowing your Malassezia and Mala s 11 antibody status before treatment can give you a heads-up about whether the head-and-neck reaction is a likely complication for you.

Asthma and Respiratory Symptoms

Mala s 11 is part of a broader family of allergy components that mimic human proteins. People with eczema who have antibodies against several of these mimicking allergens tend to have more respiratory symptoms, including asthma and rhinitis. The connection is indirect rather than diagnostic, but a high Mala s 11 result fits a pattern of more spread-out, multi-system allergic disease.

Why a Single Reading Is Not Enough

This is a relatively new test with no published reference ranges that work for everyone. Antibody levels can shift over time as your skin's microbe population changes, as you start or stop treatments, and as your eczema flares or settles. A single number gives you a snapshot. A trend tells you whether a treatment is working.

A reasonable cadence is to establish a baseline, retest in 3 to 6 months if you are making changes (starting antifungals, adjusting biologics, overhauling your skincare), and then at least annually if your eczema is ongoing. If the number moves in parallel with your skin getting better or worse, that is meaningful information you can act on.

What to Do With an Out-of-Pattern Result

A high Mala s 11 antibody result on its own does not diagnose anything. It is a clue. The next step depends on what else is going on in your skin and your broader allergy profile.

• If you have head-and-neck eczema and a high result: see a dermatologist about whether topical or oral antifungals (such as ketoconazole or itraconazole) should be added to your regimen. Studies in this group show clinical improvement with this approach.
• If you have severe, treatment-resistant eczema: pair this with a broader allergy workup, including total IgE, Malassezia mixed extract testing, and component panels for other allergens. The combination tells you whether yeast is a major driver or one of several.
• If you are considering or already taking dupilumab: flag this result with your prescriber. It does not contraindicate the medication, but it raises your odds of a head-and-neck flare on treatment.
• If you have no eczema and the result is high: this is unusual. Repeat the test with broader Malassezia extract panels to confirm, and discuss with an allergist whether further investigation is warranted.

When Results Can Be Misleading

A few things worth knowing before interpreting your number:

• Single-species testing can miss things: Mala s 11 measures antibodies against one specific protein from one specific Malassezia species. Some people are sensitized to other Malassezia species or other components that this test will not catch. A negative Mala s 11 does not rule out yeast-driven eczema.
• Sensitization is not the same as allergy: having the antibody means your immune system recognizes the protein. Whether it is actively driving your symptoms requires clinical correlation with your skin findings.
• Eczema severity varies: since antibody levels can rise and fall with disease activity, a result during a major flare may not represent your baseline.
• Skin pH matters for the yeast: Malassezia releases more allergen at the higher skin pH typical of eczema. This is one reason yeast-driven inflammation can wax and wane with your skin barrier.

Where This Test Fits

Mala s 11 antibody testing is not a routine screening tool. It is a focused, specialist-grade marker most useful in adults with stubborn or severe eczema, particularly when the pattern is head-and-neck or when standard treatments are not working. Think of it as a higher-resolution lens for understanding a specific subtype of eczema, not as a general allergy screen.